Eveline Van KeymeulenPartner at Latham & Watkins, France
Eveline Van Keymeulen is a partner in Latham & Watkins' Brussels and Paris offices and a member of the firm's Healthcare & Life Sciences Practice.
Ms. Van Keymeulen advises multinational companies and start-ups in the pharmaceutical, biotech, medical devices, cosmetics, and food and beverage sectors on a broad variety of complex European, domestic and cross-border regulatory matters, including clinical trials, product approvals, regulatory incentives, market access, promotion and advertising, post-market obligations, and general compliance matters.
In addition, Ms. Van Keymeulen has extensive experience advising on cannabis and hemp based product regulations. She successfully challenged the legality of French hemp regulations in the first landmark case related to cannabidiol (CBD) products before the Court of Justice of the European Union (Case C-663/18, Kanavape).
Ms. Van Keymeulen has authored numerous articles and has been a featured speaker on EU regulatory matters at prominent conferences such as the Pharmaceutical Law Academy in Cambridge. Ms. Van Keymeulen also serves on the editorial board of the European Pharmaceutical Law Review.
In addition, Ms. Van Keymeulen has been quoted in BBC Business Daily, Bloomberg, The Times, Les Echos and other leading international business journals on life sciences regulatory and policy matters.
Ms. Van Keymeulen is ranked in Chambers for Life Sciences Regulatory (2020) and has been recognized as a Legal 500 Rising Star / Next Generation Lawyer in Healthcare and Life Sciences (2018-2020), and as a National and Global Leader by Who's Who Legal Life Sciences (2016-2020).
"Eveline Van Keymeulen enters the rankings on the back of strong market recognition. Clients value her 'high level of energy,' with one source also appreciating her for being 'extremely flexible and genuinely engaged' as well as having 'a can-do attitude.'"
Chambers, Pharma/Life sciences: Regulatory – France 2020
“Receives effusive praise from peers this year for her adeptness on matters such as marketing authorizations and product life cycle management”
Who’s Who Legal, Life Sciences 2020
“Brilliant and sharp. She can navigate hard legal issues but she can also make our industry and its challenges simple to understand when addressing a lay audience.” The Legal 500, Healthcare and Life Sciences – Belgium 2020